The Scandinavian Prostatic Cancer Group.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003534:Cyproterone / Q000031:analogs & derivatives / Q000627:therapeutic use; D017373:Cyproterone Acetate; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D011897:Random Allocation
D000970:Antineoplastic Agents; D017373:Cyproterone Acetate; D003534:Cyproterone